Home › SEC Filings › SC 13D Beneficial Ownership
SC 13D Beneficial Ownership
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PLUR | SC 13D/A | neutral | 5/10 | 🔒Chutzpah Holdings Ltd and affiliates (Alexandre Weinstein) filed Amendment No. 6 to their Schedule 13D, disclosing that | Oct 27, 2026 |
| HEPA | SC 13D | neutral | 5/10 | 🔒Gravitas Collective Corp. filed a Schedule 13D disclosing beneficial ownership of 25,000,000 shares of Hepion Pharmaceut | Oct 26, 2026 |
| IRON | SC 13D/A | neutral | 3/10 | 🔒AI DMI LLC (Access Industries) filed Amendment No. 7 to its Schedule 13D for Disc Medicine, reporting a 6.6% beneficial | Oct 26, 2026 |
| SAFX | SC 13D/A | bearish | 6/10 | 🔒EEME Energy SPV I, LLC and its managing member Majique Ladnier filed an amended Schedule 13D disclosing a maintained 38. | Oct 26, 2026 |
| CTY | SC 13D | neutral | 5/10 | 🔒ARCH Venture Fund XII, L.P. and affiliated entities filed a Schedule 13D disclosing beneficial ownership of 13,692,507 s | Oct 26, 2026 |
| LONA | SC 13D/A | neutral | 3/10 | 🔒Perceptive Advisors LLC filed an amended Schedule 13D disclosing that its affiliate, Perceptive Xontogeny Venture Fund I | Oct 26, 2026 |
| ABEO | SC 13D | bullish | 6/10 | James Russell, through his revocable trust, filed a Schedule 13D disclosing a 6.1% stake in Abeona Therapeutics after co | Oct 23, 2026 |
| SRZN | SC 13D/A | neutral | 4/10 | The Column Group entities filed Amendment No. 7 to their Schedule 13D on Surrozen, Inc., reporting a reduction in aggreg | Oct 22, 2026 |
| INDP | SC 13D/A | neutral | 4/10 | Sino Lion Ventures Ltd and Chenhao Xu filed Amendment No. 3 to their Schedule 13D, reporting a decrease in beneficial ow | Oct 22, 2026 |
| INDP | SC 13D/A | neutral | 3/10 | Junyi Dai, CEO and Chairman of Indaptus Therapeutics, filed Amendment No. 3 to Schedule 13D reporting a passive decrease | Oct 22, 2026 |
| INDP | SC 13D/A | neutral | 4/10 | Yun Yao filed Amendment No. 3 to her Schedule 13D, reporting a decrease in her beneficial ownership percentage from a pr | Oct 22, 2026 |
| DWTX | SC 13D/A | neutral | 4/10 | Sealbond Ltd, the majority owner of Dogwood Therapeutics, filed Amendment No. 3 to its Schedule 13D, reporting a new pri | Oct 21, 2026 |
| INDP | SC 13D/A | neutral | 4/10 | Ting Yang filed Amendment No. 3 to Schedule 13D, reporting a decrease in beneficial ownership to 6.48% of Indaptus Thera | Oct 21, 2026 |
| ALXO | SC 13D/A | neutral | 4/10 | venBio Global Strategic Fund, L.P. filed Amendment No. 2 to its Schedule 13D on ALX Oncology Holdings Inc., reporting an | Oct 16, 2026 |
| LODE | SC 13D/A | bearish | 6/10 | MAK Capital Fund LP filed Amendment No. 2 to its Schedule 13D, reporting a reduction in its beneficial ownership of Coms | Oct 16, 2026 |
| OLMA | SC 13D/A | neutral | 2/10 | Biotechnology Value Fund (BVF) filed an amended Schedule 13D reporting that Dr. Gorjan Hrustanovic resigned from Olema's | Oct 16, 2026 |
| SAFX | SC 13D/A | bullish | 7/10 | EEME Energy SPV I, LLC and its managing member Majique Ladnier filed an amended Schedule 13D disclosing a significant st | Oct 16, 2026 |
| NVAX | SC 13D/A | bearish | 6/10 | Shah Capital Management filed Amendment No. 8 to its Schedule 13D, reporting a reduction in its aggregate beneficial own | Oct 16, 2026 |
| GDTC | SC 13D/A | neutral | 3/10 | Chairman Choo Chee Kong filed an amended Schedule 13D reporting open-market purchases of 29,250 ordinary shares between | Oct 16, 2026 |
| LNAI | SC 13D/A | bearish | 6/10 | William Anderson Wittekind filed Amendment No. 25 to his Schedule 13D, reporting that his beneficial ownership of Lunai | Oct 15, 2026 |
| TCRT | SC 13D/A | neutral | 6/10 | Robert W. Postma and WaterMill Asset Management Corp. filed an amended Schedule 13D disclosing a 9.99% beneficial owners | Oct 15, 2026 |
| TCRT | SC 13D | neutral | 5/10 | Fairmount Funds Management LLC and affiliates have filed a Schedule 13D disclosing beneficial ownership of 19.99% of Ala | Oct 15, 2026 |
| PBM | SC 13D/A | neutral | 5/10 | Psyence Labs Ltd. filed Amendment No. 1 to its Schedule 13D, reporting the acquisition of 1,497,500 common shares of Psy | Oct 15, 2026 |
| MXCT | SC 13D | bullish | 6/10 | Liontrust Investment Partners LLP, a UK-based investment firm, filed a Schedule 13D disclosing beneficial ownership of 5 | Oct 15, 2026 |
| EVO | SC 13D/A | bearish | 7/10 | Mubadala Investment Company PJSC and its affiliates have completely divested their entire stake in Evotec SE, selling 11 | Oct 14, 2026 |
| RTSN | SC 13D | neutral | 3/10 | CEO and co-founder Eric Keller filed a Schedule 13D disclosing beneficial ownership of 598,598 shares (7.07% of outstand | Oct 14, 2026 |
| PCRX | SC 13D/A | bearish | 7/10 | DOMA Perpetual Capital Management and its affiliates have fully exited their stake in Pacira BioSciences, selling all 2, | Oct 13, 2026 |
| GDTC | SC 13D/A | neutral | 3/10 | Chairman Choo Chee Kong filed an amended Schedule 13D disclosing open-market purchases of 62,000 ordinary shares of Cyto | Oct 13, 2026 |
| SYRE | SC 13D/A | neutral | 3/10 | Fairmount Funds Management LLC filed Amendment No. 8 to its Schedule 13D on Spyre Therapeutics, reporting no change in b | Oct 9, 2026 |
| GOSS | SC 13D/A | bearish | 5/10 | D. E. Shaw filed Amendment No. 5 to its Schedule 13D for Gossamer Bio, primarily to correct an understatement of voting | Oct 8, 2026 |
Page 1 of 2 Next »